Wednesday, November 25, 2015

HSRx Group"s Acne Product Outperforms Market Leader in Clinical Trial; Demonstrates Faster Reduction of Acne Count, Redness & Severity

TUCSON, Ariz., Nov. 18, 2015 /PRNewswire/ — In a clinical trial conducted for HSRx Group, an Arizona-based biopharmaceutical company, the OTC acne treatment product HSRx 2121 significantly outperformed a market-leading product in reducing acne count …

acne treatment – Bing News



Related Post













HSRx Group"s Acne Product Outperforms Market Leader in Clinical Trial; Demonstrates Faster Reduction of Acne Count, Redness & Severity

No comments:

Post a Comment